Background: An imbalance between reactive oxygen species (ROS) generation in sperm and antioxidant capacity of seminal plasma has been linked to male infertility. The antioxidant power of biological fl uids can be evaluated either by measurement of individual antioxidants or total antioxidant capacity (TAC). The aim of this study was to assess whether TAS Randox ® can also be used for seminal plasma antioxidant capacity estimation..
INTRODUCTION
Reactive oxygen species (ROS) have been implicated in the pathogenesis of many disease states, including infertility. Excessive ROS originating from immature sperm as well as from leukocytes can impair normal sperm function by peroxidation of unsaturated fatty acids in membrane of spermatozoa and by DNA fragmentation. On the other hand, a physiological level of ROS is crucial for sperm activation, capacitation and acrosomal reaction.
To protect spermatozoa from oxidative damage, seminal plasma is endowed with numerous enzymatic antioxidants (AOs) such as superoxide dismutase, catalase and glutathione peroxidase and a variety of non-enzymatic AOs such as ascorbate, urate, α-tocopherol, pyruvate, glutathione, taurine and hypotaurine. The endogenous AOs may be further replenished by AOs derived from food, beverages, nutritional supplements and pharmaceuticals. The imbalance between excessive ROS generation and decreased antioxidant capacity leads to the condition called oxidative stress (OS) which has been linked to idiopathic male infertility and has become a rationale for antioxidant treatment 1, 2 . The antioxidant power of biological fluids can be evaluated either by quantifi cation of individual AOs or by assessing their aggregate, cumulative action and synergic eff ect. This latter concept is known as the Total Antioxidant Capacity (TAC). The quantifi cation of individual AOs (most often superoxide dismutase and catalase) is a complicated, expensive and time consuming task. Therefore the idea of a single measurement of total antioxidant capacity (TAC) is very attractive.
Numerous principles of assays of TAC in plants, food, beverages and body fl uids have been published in the last 20 years. These include enhanced chemiluminescence (ECL) assays 3 , spectrophotometric methods such as FRAP assay 4 , CUPRAC assay 5 or methods based on the formation of the ABTS + radical 6 , fl uorometric methods such as ORAC assay 7 and electrochemical methods like coulometry 8 , voltammetry 9 or electron spin resonance assay 10 . Some of the above spectrophotometric and fl uorometric assays are now commercially available.
The ECL method using luminol for measurement of non-enzymatic antioxidants was later used for seminal plasma by several investigators 11, 12 . The ECL method is highly sensitive, but expensive and also time-consuming for use in clinical practice. A satisfactory correlation, albeit on a very small sample size, between the ECL method and the manual colorimetric method based on the formation of the radical ions, ABTS + has been reported 13 . This method has been commercialized by Randox Ltd. as the TAS (Total Antioxidant Status) Randox ® kit. The aim of our study was to assess if the automated version of this kit designed for blood serum or plasma can be used for seminal plasma, too. An additional advantage of this would be the possibility of comparing TAS levels in blood with seminal plasma levels.
MATERIALS AND METHODS
The study group included samples of 38 males from infertile couples who registered for infertility treatment at the institutional IVF centre of the Department of Obstetrics and Gynecology, University Hospital in Olomouc from September 2005 to May 2006. Twenty four healthy volunteers or semen donors served as the control group where all samples had normal sperm parameters, i.e. sperm concentration more than 20 million/ml, motility more than 50 % and more than 30 % normal sperm morphology without leukocytospermia according to WHO guidelines 14 . All males signed written informed consent for recruitment into the study approved by the Ethics Board of the Medical Faculty of Palacky University in Olomouc.
Semen samples were collected by masturbation after three to four days of sexual abstinence. After liquefaction, semen analysis was performed according to WHO guidelines. After centrifugation of liquefi ed semen (at 300 g for 7 min) the sperm pellet was washed and re-suspended in phosphate buff ered saline (PBS). ROS production in sperm suspension was immediately determined by the ECL method described elsewhere 15 . Aliquots of seminal plasma were stored in liquid nitrogen. Fasting peripheral blood for determination of plasma TAS levels was placed in pre-cooled test tubes on the day of semen examination. Serum was immediately separated in refrigerated centrifuge and its aliquots were stored at -20° C until further use. Freshly thawed batches of seminal plasma and blood serum were analyzed with the use of the TAS Randox ® kit (Cat No. NX2332, Randox laboratories, Ltd, Crumlin, UK) on the Modular SVA Analyzer. Samples were transferred into primary cups and SVA Analyzer was programmed according to the recommendation of manufacturer. Results were expressed in mM of Trolox equivalents. The linearity of calibration extends to 2.5 mmol/l of Trolox. The reference range for human blood plasma is given by the manufacturer as 1.30-1.77 mmol/l, no data being available for seminal plasma. Measurements in duplicate were used to calculate intra-assay variability.
Software STATISTICA Cz, version 6, StatSoft, Inc. (2001) was used for data analysis. The non-parametric Mann-Whitney U-test and Spearman rank correlation for evaluation of TAS levels in seminal plasma and blood serum .  Fig 1. Overlap of the histograms of ROS levels in the control and study group.
Fig 2.
Signifi cant diff erence between seminal plasma TAS levels in the control and study groups. 
RESULTS
The study group included samples of 38 males aged 24-40 years (31.7 ± 4.3) where only 14 males were normospermic and 24 males had mostly combined pathologies. The values (mean ± SD) for sperm parameters in the study group were 51 ± 33 ×10 6 /ml for sperm concentration, 44 ± 12 % for sperm motility and 26 ± 12 % for sperm morphology.
The control group included samples of 24 normospermic healthy volunteers aged 21-40 years (28.4 ± 6.2). The values (mean ± SD) for sperm parameters in the control group were 58 ± 36 ×10 6 /ml for sperm concentration, 57 ± 5 % for sperm motility and 35 ± 5 % for sperm morphology.
The ROS production in semen varied from undetectable levels to 345.000 RLU/min/2.10 7 spermatozoa in the control group and to a much greater extent, from undetectable levels up to 17 million RLU/min/2.10 7 spermatozoa in the study group, but the medians for ROS production were similar in study group (4850 RLU/min) and control group (5450 RLU/min). Fig 1 shows the overlapping histograms in both groups. The ROS production is expressed as log 10 (ROS +1).
The values (mean ± SD, range, median) for TAS in seminal plasma in the study group were signifi cantly lower (p < 0.02) than in the control group (2.15 ± 0.29 versus 2.32 ± 0.33; 1.63 -2.64 versus 1.45 -2.66; 2.11 versus 2.48, resp.). See Fig 2. Serum TAS levels were also lower in the study group compared to the control group (1.58 ± 0.20 versus 1.61 ± 0.19; 1.23-1.98 versus 1.29-1.97; 1.51 versus 1.65) but the diff erence was not signifi cant (Fig 3) .
The TAS in seminal plasma was on average 1.4 times higher than in serum. The loose positive correlation between seminal plasma and serum TAS in paired samples from subjects from the study group was statistically significant (r = 0.479, p<0.05) but individual serum values were not predictive of corresponding seminal plasma values. Similar correlation between seminal plasma and serum TAS was detected in the control group but without signifi cance probably due to a smaller number of samples in this group.
The lowest mean TAS levels in seminal plasma (2.00 ± 0.17mmol/l) as well as in blood serum (1.50 ± 0.09 mmol/l) in this study was found in samples from 5 males from infertile couples with the highest sperm ROS production.
The intra-assay coeffi cient of variation (cv) for the seminal plasma sample was 2.7 % and for the blood serum 1.9 %.
DISCUSSION
A systematic review of publications 2 that evaluate oxidative stress in semen from concluded that the literature as a whole provides contradictory fi ndings and that it is necessary to carry out more work to identify all the enzymatic and non-enzymatic systems involved in oxidative stress in sperm.
The original enhanced chemiluminescence methods to measure TAC in seminal plasma which detect non-enzymatic antioxidants are sensitive, but they require a strict control of assay conditions. This limits their introduction into clinical practice. The newer reports of seminal plasma antioxidant capacity determination by the spectrophotometric method using ABTS reaction are few and described for a limited number of subjects. Accordingly, there is no consensus on reference total antioxidant capacity of seminal plasma in healthy fertile men. One Italian group 16, 17 using TAS Randox ® reported in 25 controls mean seminal plasma TAS levels of 1.21 ± 0.16 mmol/l and in another 18 control subjects median TAS 1.19 with a range from 1.0 to 1.4 mmol/l, resp. Higher mean TAS level of 2.02 ± 0.16 mmol/l has been described in 20 fertile Turkish men 18 . Neither of the above papers specifi ed details of their procedure. Our reference values for seminal plasma derived from 24 healthy normospermic volunteers (2.32 ± 0.33 mmol/l) are so far the highest reported. It is diffi cult to speculate about the reason for the diff erences including by e.g. diff erent population, manual or automated version of TAS Randox ® kit, seminal plasma viscosity. In spite of diff erences in reference values, lower seminal plasma antioxidant capacity was found in human semen with oligoasthenospermia 16 or with astheno-and asthenoteratospermia 18 . Also our study showed signifi cantly lower (p < 0.02) TAS levels in seminal plasma in the study group of men from infertile couples with a prevalence of pathological spermiogram.
The lowest mean TAS levels in seminal plasma (2.00 ± 0.17 mmol/l) in this study was found in samples from 5 males from infertile couples with the highest sperm ROS production. This fact may be a refl ection of the reciprocal relationship between the two extremes of the oxido-reductive balance in the ejaculate.
Our pilot study suggests that TAS Randox ® kit may be used in clinical studies intended to identify decreased antioxidant power in seminal fl uid of infertile men.
